Viewing Study NCT03575234


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2025-12-27 @ 11:30 PM
Study NCT ID: NCT03575234
Status: WITHDRAWN
Last Update Posted: 2019-08-28
First Post: 2018-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer
Sponsor: Emory University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module